Long-term Survivors and Failures of CAR-T Therapy for Lymphoma: Is there a Role for Allogeneic Transplantation After the CAR-T Crash?

被引:0
|
作者
Spinner, Michael A. [1 ]
Komanduri, Krishna, V [1 ]
机构
[1] Univ Calif San Francisco, Dept Med, Div Hematol Oncol, San Francisco, CA 94115 USA
来源
TRANSPLANTATION AND CELLULAR THERAPY | 2023年 / 29卷 / 12期
关键词
B-CELL LYMPHOMA;
D O I
10.1016/j.jtct.2023.11.003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:725 / 726
页数:2
相关论文
共 50 条
  • [21] Biomarkers for CAR-T Cell Therapy
    不详
    TRANSFUSIONSMEDIZIN, 2024, 14 (03) : 123 - 124
  • [22] BCMA CAR-T AFTER ALLOGENEIC HCT INDUCES REMISSION IN REFRACTORY PLASMABLASTIC LYMPHOMA
    Raghunandan, Sharmila
    Pauly, Melinda
    Blum, William
    Qayed, Muna
    Dhodapkar, Madhav
    Elkhalifa, Mohamed
    Watkins, Benjamin
    Schoettler, Michelle
    Horwitz, Edwin
    Parikh, Suhag
    Chandrakasan, Shanmuganathan
    Leung, Kathryn
    Bryson, Elyse
    Deeb, Laura
    Kaufman, Jonathan
    Worthington-White, Diana
    Alazraki, Adina
    Schecter, Jordan
    Madduri, Deepu
    Jackson, Carolyn
    Zudaire, Enrique
    Taraseviciute-Morris, Agne
    Babich, Alexander
    Nesheiwat, Tonia
    Vogel, Martin
    Lendvai, Nikoletta
    Williams, Kirsten
    PEDIATRIC BLOOD & CANCER, 2022, 69
  • [23] Secondary Malignancies after CAR-T Cell Therapy
    Rudek, Loreen Sophie
    Alakus, Hakan
    ONKOLOGIE, 2025, 31 (01): : 110 - 111
  • [24] Molecular mechanisms promoting long-term cytopenia after BCMA CAR-T therapy in multiple myeloma
    Palacios-Berraquero, Maria Luisa
    Rodriguez-Marquez, Paula
    Calleja-Cervantes, Maria Erendira
    Berastegui, Nerea
    Zabaleta, Aintzane
    Burgos, Leire
    Alignani, Diego
    San Martin-Uriz, Patxi
    Vilas-Zornoza, Amaia
    Rodriguez-Diaz, Saray
    Inoges, Susana
    de Cerio, Ascension Lopez-Diaz
    Tamariz, Esteban
    Rifon, Jose
    Alfonso-Pierola, Ana
    Lasarte, Juan Jose
    Paiva, Bruno
    Hernaez, Mikel
    Rodriguez-Otero, Paula
    San-Miguel, Jesus
    Ezponda, Teresa
    Roberto, Juan
    Prosper, Felipe
    BLOOD ADVANCES, 2024, 8 (21) : 5479 - 5492
  • [25] CAR-T Cell Therapy and Beyond
    Dotti, Gianpietro
    PEDIATRIC BLOOD & CANCER, 2017, 64 : S4 - S4
  • [26] Target selection for CAR-T therapy
    Wei, Jianshu
    Han, Xiao
    Bo, Jian
    Han, Weidong
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2019, 12 (1)
  • [27] CAR-T Cell Therapy for Patients with aggressive Lymphomas Prospect of Long-term Remission
    Arnheim, Katharina
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 (12) : 694 - 695
  • [28] Building safety into CAR-T therapy
    Peters, Daniel T.
    Savoldo, Barbara
    Grover, Natalie S.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2023, 19 (03)
  • [29] CAR-T Cell Therapy and the Neurointensivist
    Wijdicks, Eelco F. M.
    Rabinstein, Alejandro A.
    Lin, Yi
    NEUROCRITICAL CARE, 2024, : 691 - 694
  • [30] Optimizing CAR-T Therapy for Glioblastoma
    Oliver Y. Tang
    Zev A. Binder
    Donald M. O’Rourke
    Stephen J. Bagley
    Molecular Diagnosis & Therapy, 2023, 27 : 643 - 660